Chubb's Combined Canada Launches Cancer Care Insurance to Address Rising Out-of-Pocket Costs
Event summary
- Combined Canada, a Chubb Benefits Company, launched Combined Cancer Care on May 13, 2026, a new insurance product designed to help Canadians manage financial challenges associated with cancer diagnoses.
- The product offers daily benefits for inpatient and outpatient care (up to $400 per day), optional lump-sum diagnosis benefits ($2,500 to $10,000), and coverage for heart attack and stroke protection.
- Combined Cancer Care includes access to Teladoc Health Canada's Expert Medical Services and flexible policy structures for palliative care and lifetime coverage.
- The launch is part of Combined Canada's strategy to expand its presence in the supplemental health market, addressing the growing financial burden of cancer-related costs.
The big picture
The launch of Combined Cancer Care reflects Chubb's strategic focus on expanding its supplemental health offerings amid rising healthcare costs and increasing cancer diagnoses in Canada. With nearly 2 in 5 Canadians expected to develop cancer in their lifetime, the product addresses a critical gap in financial protection for patients and their families. This move aligns with broader industry trends toward specialized insurance solutions that complement traditional healthcare coverage.
What we're watching
- Market Adoption
- How quickly Combined Cancer Care gains traction among Canadians facing cancer diagnoses and the financial strain associated with treatment.
- Competitive Response
- Whether other insurers in Canada will introduce similar products to address the growing need for supplemental cancer care coverage.
- Regulatory Impact
- The potential for regulatory changes that could influence the availability or structure of supplemental health insurance products in Canada.
Related topics